Search research articles
Contact Us
Filters
Showing results (101-110 of 142) with videos related to
Page
of 15
Sort By:
Genomics
|
April 11, 2000
Peptide YY-2 (PYY2) and pancreatic polypeptide-2 (PPY2): species-specific evolution of novel members of the neuropeptide Y gene family
M Couzens, M Liu, C Tüchler, et al.
Cancer Research
|
January 19, 1999
Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines
T Putz, Z Culig, I E Eder, et al.
European Urology
|
January 1, 1995
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor
Z Culig, A Hobisch, M V Cronauer, et al.
The Prostate
|
July 1, 1997
Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cells
Z Culig, A Hobisch, A Hittmair, et al.
Cancer Research
|
October 15, 1994
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor
Z Culig, A Hobisch, M V Cronauer, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
December 1, 1993
Characterization of two point mutations in the androgen receptor gene of patients with perineoscrotal hypospadia
F Kaspar, A C Cato, A Denninger, et al.
Urology
|
September 11, 2001
Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria
G Bartsch, W Horninger, H Klocker, et al.
Prostate Cancer and Prostatic Diseases
|
October 30, 2013
[-2]proPSA is an early marker for prostate cancer aggressiveness
I Heidegger, H Klocker, E Steiner, et al.
British Journal of Cancer
|
July 4, 2014
EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205
P Massoner, T Thomm, B Mack, et al.
The Prostate
|
June 1, 1996
Regulation of prostatic growth and function by peptide growth factors
Z Culig, A Hobisch, M V Cronauer, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 142) with videos related to
Sort By:
Page
of 15
Genomics
|
April 11, 2000
Peptide YY-2 (PYY2) and pancreatic polypeptide-2 (PPY2): species-specific evolution of novel members of the neuropeptide Y gene family
M Couzens, M Liu, C Tüchler, et al.
Cancer Research
|
January 19, 1999
Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines
T Putz, Z Culig, I E Eder, et al.
European Urology
|
January 1, 1995
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor
Z Culig, A Hobisch, M V Cronauer, et al.
The Prostate
|
July 1, 1997
Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cells
Z Culig, A Hobisch, A Hittmair, et al.
Cancer Research
|
October 15, 1994
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor
Z Culig, A Hobisch, M V Cronauer, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
December 1, 1993
Characterization of two point mutations in the androgen receptor gene of patients with perineoscrotal hypospadia
F Kaspar, A C Cato, A Denninger, et al.
Urology
|
September 11, 2001
Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria
G Bartsch, W Horninger, H Klocker, et al.
Prostate Cancer and Prostatic Diseases
|
October 30, 2013
[-2]proPSA is an early marker for prostate cancer aggressiveness
I Heidegger, H Klocker, E Steiner, et al.
British Journal of Cancer
|
July 4, 2014
EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205
P Massoner, T Thomm, B Mack, et al.
The Prostate
|
June 1, 1996
Regulation of prostatic growth and function by peptide growth factors
Z Culig, A Hobisch, M V Cronauer, et al.
Page
of 15